• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OBTECH MEDICAL SARL_; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OBTECH MEDICAL SARL_; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number RLZB22
Device Problem Human-Device Interface Problem (2949)
Patient Problems Vomiting (2144); Surgical procedure, additional (2564)
Event Date 11/14/2014
Event Type  Injury  
Event Description
It was reporte that the subject had esophageal dilation on ugi dated (b)(6) 2011.At this time, she began having fluid taken out of band.As dilation resolved with loosening, re-adjustment proved intolerable with vomiting and recurrent dilations.Ugi on (b)(6) 2014 showed tertiary waves and esophageal manometry revealed esophageal dysfunction/dysmotility.Band adjustment manipulation continued until november when subject and investigator determined the band would need to be removed.Planned surgical date ¿ (b)(6) 2014.
 
Manufacturer Narrative
(b)(4): information anticipated, but unavailable at this time.When additional information is received and/or the device analysis has been completed, a supplemental medwatch will be sent.
 
Manufacturer Narrative
(b)(4).Additional information: the complaint cannot be confirmed.Product analysis cannot confirm events that are physiological in nature.The returned device was visually inspected, it was noted that per the analysis no anomalies with respect to device appearance.A device history record (dhr) review was performed, and no discrepancies were recorded during the manufacturing process.While it is not possible to draw a definitive conclusion regarding root cause of the reported event, vomiting, intolerance, and esophageal distention or dilatation are recognized adverse event associated to gastric banding; the product's instruction for use (ifu) provides detailed information on potential causes and consequences.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
OBTECH MEDICAL SARL_
chemin-blanc 38
le locle CH-24 00
SZ  CH-2400
Manufacturer (Section G)
OBTECH MEDICAL SARL
chemin-blanc 38
le locle CH-2 400
SZ   CH-2400
Manufacturer Contact
guillermo villa
route 22 west po box 151
somerville, NJ 08876
9082180707
MDR Report Key4316899
MDR Text Key20453335
Report Number3005992282-2014-00069
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/02/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2014
Device Catalogue NumberRLZB22
Device Lot NumberZKBBCF
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/21/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/23/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/11/2009
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-